North Carolina Governor Josh Stein announced that pharmaceutical giant Johnson & Johnson (J&J) will expand its presence in the state with a multibillion-dollar investment in a drug product manufacturing facility in Wilson. J&J stated that the …

(The Center Square) – Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to open in eastern North Carolina. Nearly $80 million in incentives brought the first plant to Wilson County in …

Decoy Therapeutics will use the platform, with funding support from the Gates Foundation, to provide widespread access to peptide-conjugate antivirals from Decoy's IMP3ACT™ platform for low- and middle-income countries. CAMBRIDGE, Mass. and HOUSTON, …

… to construct a $2 billion pharmaceutical manufacturing campus in the city … in 2025), targeting manufacturing, research & development, and technology infrastructure up to … edpnc.com/news/johnson-johnson-building-another-multibillion-dollar-facility …

Lewes, Delawa, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Global Stem Cell Therapy Market Size is projected to grow at a CAGR of 10.97% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was …

VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The biotechnology sector is entering a high-stakes survival sprint as major pharmaceutical giants confront a looming $170 billion patent cliff[1]. This …

Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in- …

Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership with announced transactions of $4.7 billion Multiple potential value-creating milestones expected across …

The fountain at the Pennsylvania Capitol in Harrisburg. Photo by Amanda Berg / For Spotlight PA. HARRISBURG, Pa. (EYT) — Johnson & Johnson plans to build a next-generation cell therapy manufacturing facility in Pennsylvania, continuing its long- …

HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), a clinical stage innovative drug development company focused on developing innovative therapies …